Fate Therapeutics Inc 内部交易概览
最近18个月交易的高管股东 | 交易次数 | 净买入(股) |
---|---|---|
Dulac Edward J Iii | 5 | -26,108 |
Redmile Group, Llc | 4 | 44,630 |
Cindy Tahl | 3 | -46,790 |
J Scott Wolchko | 2 | -60,298 |
Bahram Valamehr | 2 | -22,188 |
Yu-waye Chu | 2 | -10,357 |
交易分段汇总 | 买入数量 | 卖出数量 | 净买入(股) |
---|---|---|---|
最近1个月 | 0 | 0 | 0 |
最近3个月 | 0 | 1,849 | -1,849 |
最近6个月 | 44,630 | 69,776 | -25,146 |
最近12个月 | 44,630 | 87,622 | -42,992 |
最近18个月 | 471,648 | 479,444 | -7,796 |
最近36个月 | 471,648 | 484,579 | -12,931 |
Fate Therapeutics Inc 内部交易
Fate Therapeutics Inc 最新内部交易
Dulac Edward J Iii | CFO | 2024-01-29 | 卖出 | 1,849 | 103,926 |
$5
|
-24.00%
|
J Scott Wolchko | President & CEO | 2024-01-09 | 卖出 | 14,391 | 371,248 |
$4.37
|
-13.04%
|
Dulac Edward J Iii | CFO | 2024-01-09 | 卖出 | 7,028 | 105,775 |
$4.37
|
-13.04%
|
Bahram Valamehr | Chief R&D Officer | 2024-01-09 | 卖出 | 11,271 | 158,069 |
$4.38
|
-13.24%
|
Cindy Tahl | General Counsel & Secretary | 2024-01-09 | 卖出 | 10,874 | 142,361 |
$4.37
|
-13.04%
|
Redmile Group, Llc | Director, 10% Owner | 2023-12-26 | 买入 | 44,630 | 13,180,388 |
$3.72
|
+2.15%
|
Cindy Tahl | General Counsel & Secretary | 2023-11-09 | 卖出 | 24,363 | 153,235 |
$2.4
|
+58.33%
|
Dulac Edward J Iii | CFO | 2023-08-18 | 卖出 | 4,718 | 119,570 |
$2.8
|
+35.71%
|
Yuan Xu | 董事 | 2023-08-04 | 卖出 | 632 | 9,302 |
$3.71
|
+2.43%
|
Dulac Edward J Iii | CFO | 2023-07-05 | 卖出 | 5,182 | 124,288 |
$4.83
|
-21.33%
|